Company: JUNS
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001493152-25-023603
Chunk: 14

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-14
Form: 10-Q
Item: Item 8
Chunk 14
---
Stock Units

Certain
shares previously presented as issued and outstanding in connection with vested restricted stock units were not legally issued due to
administrative delays and, accordingly, were removed from shares outstanding as of September 30, 2025. The correction reduced shares
outstanding from 34,833,083 at June 30, 2025 to 34,294,546 at September 30, 2025, a decrease of 538,537 shares, and resulted in a non-cash
reclassification of $163 between common stock and additional paid-in capital. The impact was immaterial to basic and diluted EPS and
did not have a material effect on the condensed consolidated balance sheet.

Therefore,
no restricted stock units were issued during the nine months ended September 30, 2025. In June 2025, all then issued and outstanding
restricted stock units of 1,626,037 were fully vested.

Note
7 – Commitments and Contingencies

Legal
Matters

In the ordinary course of business, we are from time to time involved in
lawsuits, claims, investigations, proceedings, and threats of litigation relating to, among other things, intellectual property, commercial
arrangements, employment, and regulatory matters. While the outcome of these proceedings and claims cannot be predicted with certainty,
as of September 30, 2025, we were not party to any material legal or arbitration proceedings. No governmental proceedings are pending
or, to our knowledge, contemplated against us.

    19

JUPITER
NEUROSCIENCES, INC.

NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Note
7 – Commitments and Contingencies, continued

Leases

On
May 1, 2021, the Company entered into a 61-month operating lease for office space for a base rent of $3,783 subject to a 3% yearly escalation.

As
of September 30, 2025 and December 31, 2024, the Company’s operating lease right-of-use asset, net (ROU) is $34,821 and $69,642,
respectively. Related lease liability totaled $33,961 and $71,329, respectively, based on an incremental borrowing rate at lease inception.

 Schedule of Operating Lease Right-of-use Asset and Liability

    September
    30,  
    December
    31, 

    2025  
    2024